Drug Type Chemical drugs |
Synonyms |
Target |
Mechanism BET1 inhibitors(Bet1 golgi vesicular membrane trafficking protein inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization AevisBio, Inc.Startup |
Active Organization AevisBio, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Multiple Myeloma | Preclinical | US | AevisBio, Inc.Startup | 15 May 2024 |
Acute Myeloid Leukemia | Discovery | US | AevisBio, Inc.Startup | 03 Jun 2024 |